CIM
VCYT icon

Contravisory Investment Management’s Veracyte VCYT Stock Holding History

Contravisory Investment Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,849
Closed -$243K – 390
2023
Q4 		$243K Hold
8,849
– – 0.06% 188
2023
Q3 		$198K Buy
+8,849
New +$228K 0.06% 195

Other funds holding VCYT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Contravisory Investment Management's VCYT Position: Q1 2024 in Review

Contravisory Investment Management sold out of Veracyte (VCYT) in Q1 2024, closing a stake of 8,849 shares — an estimated $243K sold.

Contravisory Investment Management first reported a position in VCYT in Q3 2023 and held it in 2 quarters. The position peaked at $243K in Q4 2023. 246 funds tracked by Wall St. Rank hold VCYT as of Q1 2024.

  • Contravisory Investment Management reported no remaining Veracyte position as of Q1 2024 after selling out during the quarter.
  • Contravisory Investment Management sold 8,849 Veracyte shares in Q1 2024, an estimated $243K.
  • Contravisory Investment Management first reported a position in Veracyte in Q3 2023 and held it in 2 quarters.
  • Contravisory Investment Management's Veracyte position peaked at $243K in Q4 2023.
  • 246 funds tracked by Wall St. Rank held Veracyte as of Q1 2024.

Based on Contravisory Investment Management's 13F filing for Q1 2024, filed 11 Apr 2024.